报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 78.83% | 2.49% | 2.97% | 19/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 76.56% | 1.98% | 7.14% | 20/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 71.46% | 2.77% | -5.61% | 29/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 75.71% | -9.62% | -1.58% | 24/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 76.92% | -8.78% | 2.46% | 24/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 75.07% | -11.64% | 7.96% | 26/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 69.54% | -16.37% | -16.99% | 30/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 83.77% | 0.11% | -0.66% | 20/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 84.33% | 0.13% | -0.75% | 20/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 84.97% | 0.98% | 2.18% | 20/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 83.15% | 2% | -0.64% | 21/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 83.68% | 0.18% | -0.64% | 22/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 84.22% | 2% | 0.09% | 23/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 84.14% | -1.18% | 0.73% | 23/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2020-12-31 | 83.53% | -3.09% | -1.89% | 24/54 | 71.61% | 义翘神州 | 96.83% | 行业排名> |
2020-06-30 | 85.14% | 2% | -1.22% | 19/54 | 88.2% | 义翘神州 | 96.88% | 行业排名> |
2019-12-31 | 86.2% | 0.6% | 0.6% | 17/54 | 72.44% | 义翘神州 | 96.56% | 行业排名> |
2018-12-31 | 85.69% | 4.92% | 4.92% | 13/54 | 71.54% | 华兰疫苗 | 707.43% | 行业排名> |
2017-12-31 | 81.67% | 2% | 2% | 12/54 | -887.82% | 我武生物 | 95.6% | 行业排名> |